Sushilkumar Patil
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 8
- Drug Solubulity and Delivery Systems 4
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Ambikanandan R. Misra (20 shared papers)Imran Vhora (13 shared papers)Dipesh Baradia (5 shared papers)Girish G. Kore (3 shared papers)Chetan R. Yewale (3 shared papers)Priyanka Bhatt (9 shared papers)Rohan Lalani (8 shared papers)Jitendra Amrutiya (7 shared papers)
- Journals
- International Journal of Pharmaceutics (3 papers)RSC Advances (2 papers)Current Pharmaceutical Design (2 papers)Therapeutic Delivery (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- IndiaCanadaUnited States
In The Last Decade
Sushilkumar Patil
21 papers receiving 1.7k citations
Sushilkumar Patil's Hit Papers
Peers
Comparison fields: 5 of 114
- Pharmaceutical Science 270
- Biomaterials 543
- Molecular Medicine 66
- Oncology 271
- Molecular Biology 725
Countries citing papers authored by Sushilkumar Patil
This map shows the geographic impact of Sushilkumar Patil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sushilkumar Patil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sushilkumar Patil more than expected).
Fields of papers citing papers by Sushilkumar Patil
This network shows the impact of papers produced by Sushilkumar Patil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sushilkumar Patil. The network helps show where Sushilkumar Patil may publish in the future.
Co-authors
The 17 scholars most cited alongside Sushilkumar Patil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PEG — A versatile conjugating ligand for drugs and drug delivery systems Hit paper breakdown → | 2014 | 577 |
| 2 | Epidermal growth factor receptor targeting in cancer: A review of trends and strategies Hit paper breakdown → | 2013 | 444 |
| 3 | 2017 | 141 | |
| 4 | 2015 | 89 | |
| 5 | 2014 | 63 | |
| 6 | 2017 | 60 | |
| 7 | 2019 | 60 | |
| 8 | 2016 | 49 | |
| 9 | 2014 | 43 | |
| 10 | 2018 | 41 | |
| 11 | 2016 | 39 | |
| 12 | 2018 | 30 | |
| 13 | 2018 | 30 | |
| 14 | 2015 | 25 | |
| 15 | 2015 | 19 | |
| 16 | 2014 | 16 | |
| 17 | 2021 | 11 | |
| 18 | 2015 | 10 | |
| 19 | 2020 | 4 | |
| 20 | 1992 | 1 |
About Sushilkumar Patil
Sushilkumar Patil is a scholar working on Pharmaceutical Science, Biomaterials, Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Advanced Drug Delivery Systems (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Advanced biosensing and bioanalysis techniques (7 papers), Drug Solubulity and Delivery Systems (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Pharmaceutical Science (270 citations), Biomaterials (543 citations), Molecular Medicine (66 citations), Oncology (271 citations) and Molecular Biology (725 citations). Sushilkumar Patil has collaborated with scholars based in India, Canada and United States. Frequent co-authors include Ambikanandan R. Misra, Imran Vhora, Dipesh Baradia, Girish G. Kore, Chetan R. Yewale, Priyanka Bhatt, Rohan Lalani, Jitendra Amrutiya, Rajashree C. Mashru and Pierre Lesimple. Their work appears in journals such as International Journal of Pharmaceutics, RSC Advances, Current Pharmaceutical Design, Therapeutic Delivery and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.